Clinical trial
Autologous Cord Blood Cells for Patients With HLHS: Phase I Study of Feasibility and Safety
NCT01445041 is registered in ClinicalTrials.gov with Michael Cotten as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Cord Blood Cells for Patients With HLHS: Phase I Study of Feasibility and Safety
- Lead sponsor
- Michael Cotten
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- September 1, 2011
- Completion date
- April 15, 2016
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.